Header Logo

Catherine A Phillips MD

TitleAssociate Professor
InstitutionUMass Chan Medical School
DepartmentNeurology
AddressUMass Chan Medical School
55 Lake Avenue North
Worcester MA 01655
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentNeurology


    Collapse Biography 
    Collapse education and training
    Oberlin College, Oberlin, OH, United StatesBAArts
    University of California, San Francisco, San Francisco, CA, United StatesMD

    Collapse Overview 
    Collapse Summary
    Dr. Phillips specializes in the management of refractory seizures, surgical treatment of epilepsy, and in all aspects of electroencephalography and epilepsy.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mah L, Swearer J, Phillips CA, Benjamin S. Reduction in apathy following epilepsy surgery. Neuropsychiatr Dis Treat. 2019; 15:1679-1684. PMID: 31388300.
      Citations:    
    2. Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Dobrzanski MJ, Lockwood-Cooke PR, Robinson W. Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot study. J Immunother. 2012 Feb-Mar; 35(2):196-204. PMID: 22306908.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    3. Dobrzanski MJ, Rewers-Felkins KA, Samad KA, Quinlin IS, Phillips CA, Robinson W, Dobrzanski DJ, Wright SE. Immunotherapy with IL-10- and IFN-?-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer. Cancer Immunol Immunother. 2012 Jun; 61(6):839-54. PMID: 22083345.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    4. Wright SE, Quinlin IS, Rewers-Felkins KA, Dombrowski KE, Phillips CA. Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions. Immunopharmacol Immunotoxicol. 2010 Dec; 32(4):647-55. PMID: 20470225.
      Citations: 1     Fields:    Translation:HumansCells
    5. Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study. Immunol Invest. 2010; 39(6):570-86. PMID: 20653425.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    6. Dobrzanski MJ, Rewers-Felkins KA, Quinlin IS, Samad KA, Phillips CA, Robinson W, Dobrzanski DJ, Wright SE. Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival. Clin Immunol. 2009 Dec; 133(3):333-52. PMID: 19762283.
      Citations: 16     Fields:    Translation:HumansCells
    7. Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II study. Immunol Invest. 2009; 38(8):820-38. PMID: 19860591.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    8. Wright SE, Rewers-Felkins KA, Quinlin IS, Fogler WE, Phillips CA, Townsend M, Robinson W, Philip R. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells. Immunol Invest. 2008; 37(3):215-25. PMID: 18389441.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    9. Orr MK, Burnside JS, Phillips CA, Philip R, Dombrowski KE, Wright SE. MHC-restricted presentation of a single repeat of MUC1 mucin. Immunol Invest. 2007; 36(3):271-83. PMID: 17558710.
      Citations:    Fields:    Translation:Cells
    10. Wright SE, Rewers-Felkins KA, Quinlin IS, Eldridge PW, Zorsky PE, Klug PP, Phillips CA, Philip R. Adoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cells. Int J Mol Med. 2002 Apr; 9(4):401-4. PMID: 11891536.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    Phillips's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (70)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _